One study found that when DRAK2 expression was inhibited, mice develop resistance to a T-cell-mediated autoimmune disease—experimental autoimmune encephalomyelitis (EAE) (McGargill et al., 2008; Ramos et al., 2008), and it is also resistant to type I diabetes. The gene discussed is STK17B; the disease is type 1 diabetes mellitus.